Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
J Invest Dermatol (2010) 130(11):264753
Rinalducci S et al
Insulin-like growth factor-1 promotes cell cycle progression via upregulation of cyclin D1 expression through the phosphatidylinositol 3-kinase/nuclear factor-B signaling pathway in FRTL thyroid cells
Dementia, Alzheimers Disesae, Parkinsons disease, depression, kidney function, male and female fertility, prevention of diabetes, cardiovascular events such as heart attacks, and more
Key Takeaways Injectable GHK-Cu: 12mg per injection, once or twice daily Topical GHK-Cu cream/serum: 24% concentration, once or twice daily Cycle length: 812 weeks on, 4 weeks off 100mg vial at 2mg/day = 50 days of use Results start showing at weeks 34, significant at weeks 68 Most popular setup: 100mg vial + 2mL BAC water = 50mg/mL concentration Free calculator: Reconstitution Calculator The standard injectable GHK-Cu dose is 12mg per day, subcutaneously
:max_bytes(150000):strip_icc()/Wegovy-pill-pic-590ed53ed3304ba8b2388f9d78886dae.png)
US$ 28.40
US$ 26.64
US$ 26.48
